{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:59:02Z","timestamp":1790787542281,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":497,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1038\/s41379-021-00817-7","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T08:02:23Z","timestamp":1620979343000},"page":"1673-1685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Myeloid\/lymphoid neoplasms with FLT3 rearrangement"],"prefix":"10.1016","volume":"34","author":[{"given":"Guilin","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4283-0005","authenticated-orcid":false,"given":"Wayne","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Short","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithviraj","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6975-9168","authenticated-orcid":false,"given":"Stephanie N.","family":"Hurwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8491-224X","authenticated-orcid":false,"given":"Heesun J.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8623-4067","authenticated-orcid":false,"given":"Eric D.","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres E.","family":"Quesada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8467-5464","authenticated-orcid":false,"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.","family":"Bueso-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6577-8006","authenticated-orcid":false,"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Hasserjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Arber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Orazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Foucar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-021-00817-7_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0378-1119(94)90021-3","article-title":"Genomic structure of the downstream part of the human FLT3 gene: exon\/intron structure conservation among genes encoding receptor tyrosine kinases (RTK) of subclass III","volume":"145","author":"Agnes","year":"1994","journal-title":"Gene"},{"key":"10.1038\/s41379-021-00817-7_bib2","first-page":"595","article-title":"Hematopoietic receptors of class III receptor-type tyrosine kinases","volume":"4","author":"Rosnet","year":"1993","journal-title":"Crit Rev Oncog"},{"key":"10.1038\/s41379-021-00817-7_bib3","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1182\/blood.V99.12.4326","article-title":"Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis","volume":"99","author":"Thiede","year":"2002","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00817-7_bib4","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1182\/blood.V97.8.2434","article-title":"Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies","volume":"97","author":"Yamamoto","year":"2001","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00817-7_bib5","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/sj.leu.2400812","article-title":"Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines","volume":"11","author":"Yokota","year":"1997","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00817-7_bib6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc1169","article-title":"The role of FLT3 in haematopoietic malignancies","volume":"3","author":"Stirewalt","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/s41379-021-00817-7_bib7","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/sj.leu.2400770","article-title":"Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia","volume":"11","author":"Horiike","year":"1997","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00817-7_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood.V100.1.59","article-title":"Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease","volume":"100","author":"Schnittger","year":"2002","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00817-7_bib9","first-page":"7","article-title":"ETV6\/FLT3 fusion in a mixed-phenotype acute leukemia arising in lymph nodes in a patient with myeloproliferative neoplasm with eosinophilia","volume":"7","author":"Hosseini","year":"2014","journal-title":"J Hematopath"},{"key":"10.1038\/s41379-021-00817-7_bib10","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1182\/blood-2011-03-343426","article-title":"Response of ETV6-FLT3-positive myeloid\/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3","volume":"118","author":"Walz","year":"2011","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00817-7_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00277-013-1843-9","article-title":"Successful allogeneic stem cell transplantation with long-term remission of ETV6\/FLT3-positive myeloid\/lymphoid neoplasm with eosinophilia","volume":"93","author":"Chonabayashi","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1038\/s41379-021-00817-7_bib12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/leu.2016.304","article-title":"A novel t(3;13)(q13;q12) translocation fusing FLT3 with GOLGB1: toward myeloid\/lymphoid neoplasms with eosinophilia and rearrangement of FLT3?","volume":"31","author":"Troadec","year":"2017","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00817-7_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cancergen.2017.05.001","article-title":"A novel TRIP11-FLT3 fusion in a patient with a myeloid\/lymphoid neoplasm with eosinophilia","volume":"216-217","author":"Chung","year":"2017","journal-title":"Cancer Genet"},{"key":"10.1038\/s41379-021-00817-7_bib14","doi-asserted-by":"crossref","unstructured":"Munthe-Kaas MC, Forthun RB, Brendehaug A, Eek AK, Hoysaeter T, Osnes LTN, et al. Partial response to sorafenib in a child with a myeloid\/lymphoid neoplasm, eosinophilia, and a ZMYM2-FLT3 fusion. J Pediatr Hematol Oncol. 2020. https:\/\/doi.org\/10.1097\/MPH.0000000000001890.","DOI":"10.1097\/MPH.0000000000001890"},{"key":"10.1038\/s41379-021-00817-7_bib15","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1038\/leu.2014.168","article-title":"ETV6-FLT3 fusion gene-positive, eosinophilia-associated myeloproliferative neoplasm successfully treated with sorafenib and allogeneic stem cell transplant","volume":"28","author":"Falchi","year":"2014","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00817-7_bib16","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/sj.leu.2404266","article-title":"FLT3 is fused to ETV6 in a myeloproliferative disorder with hypereosinophilia and a t(12;13)(p13;q12) translocation","volume":"20","author":"Vu","year":"2006","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00817-7_bib17","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/leu.2017.240","article-title":"Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia","volume":"31","author":"Jawhar","year":"2017","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00817-7_bib18","doi-asserted-by":"crossref","first-page":"a003079","DOI":"10.1101\/mcs.a003079","article-title":"Two myeloid leukemia cases with rare FLT3 fusions","volume":"4","author":"Zhang","year":"2018","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"10.1038\/s41379-021-00817-7_bib19","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.exphem.2007.07.002","article-title":"A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy","volume":"35","author":"Grand","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1038\/s41379-021-00817-7_bib20","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41375-019-0549-y","article-title":"Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing","volume":"34","author":"Chao","year":"2020","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00817-7_bib21","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/jcp.2008.058073","article-title":"Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3","volume":"61","author":"Tzankov","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1038\/s41379-021-00817-7_bib22","doi-asserted-by":"crossref","first-page":"106460","DOI":"10.1016\/j.leukres.2020.106460","article-title":"Myeloid\/lymphoid neoplasms with eosinophilia and FLT3 rearrangement","volume":"99","author":"Shao","year":"2020","journal-title":"Leuk Res"},{"key":"10.1038\/s41379-021-00817-7_bib23","unstructured":"Brain BJ, Honry HP, Arber DA, Tefferi A, Hasserjian RP Myeloid\/lymphoid neoplasms with eosinophilia and rearrangements of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2. In: Swerdlow S et al. (eds). WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th edition. Lyon: International Agency for Research on Cancer (IARC); 2017."},{"key":"10.1038\/s41379-021-00817-7_bib24","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.6004\/jnccn.2020.0042","article-title":"Myeloid\/lymphoid neoplasms with eosinophilia and TK fusion genes, version 3.2021, NCCN clinical practice guidelines in oncology","volume":"18","author":"Gerds","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1038\/s41379-021-00817-7_bib25","first-page":"1128","article-title":"European consensus on grading bone marrow fibrosis and assessment of cellularity","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematologica"},{"key":"10.1038\/s41379-021-00817-7_bib26","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/modpathol.2016.75","article-title":"Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified","volume":"29","author":"Wang","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00817-7_bib27","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3324\/haematol.2017.165340","article-title":"Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome","volume":"102","author":"Wang","year":"2017","journal-title":"Haematologica"},{"key":"10.1038\/s41379-021-00817-7_bib28","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/his.14097","article-title":"Systematic use of fluorescence in-situ hybridisation and clinicopathological features in the screening of PDGFRB rearrangements of patients with myeloid\/lymphoid neoplasms","volume":"76","author":"Fang","year":"2020","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00817-7_bib29","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/nm.3729","article-title":"Anchored multiplex PCR for targeted next-generation sequencing","volume":"20","author":"Zheng","year":"2014","journal-title":"Nat Med"},{"key":"10.1038\/s41379-021-00817-7_bib30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41379-018-0165-9","article-title":"Hematopoietic neoplasms with 9p24\/JAK2 rearrangement: a multicenter study","volume":"32","author":"Tang","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00817-7_bib31","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.3324\/haematol.2017.187302","article-title":"Molecular genetic characterization of myeloid\/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2","volume":"103","author":"Baer","year":"2018","journal-title":"Haematologica"},{"key":"10.1038\/s41379-021-00817-7_bib32","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/sj.leu.2404532","article-title":"Transgenic mice expressing Tel-FLT3, a constitutively activated form of FLT3, develop myeloproliferative disease","volume":"21","author":"Baldwin","year":"2007","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00817-7_bib33","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/sj.onc.1205332","article-title":"Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain","volume":"21","author":"Kiyoi","year":"2002","journal-title":"Oncogene"},{"key":"10.1038\/s41379-021-00817-7_bib34","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.3324\/haematol.2014.105452","article-title":"PDGFRB-rearranged T-lymphoblastic leukemia\/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin","volume":"99","author":"Ondrejka","year":"2014","journal-title":"Haematologica"},{"key":"10.1038\/s41379-021-00817-7_bib35","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/bjh.12834","article-title":"ATF7IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in children","volume":"165","author":"Kobayashi","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1038\/s41379-021-00817-7_bib36","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00817-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00817-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00817-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:36:45Z","timestamp":1760229405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222005464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0893395222005464"],"URL":"https:\/\/doi.org\/10.1038\/s41379-021-00817-7","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid\/lymphoid neoplasms with FLT3 rearrangement","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-021-00817-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}